ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ipsen SA

Ipsen SA (IPN)

114.50
-0.60
(-0.52%)
Closed May 05 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
114.50
Bid
114.20
Ask
115.60
Volume
42,555
113.90 Day's Range 115.80
99.70 52 Week Range 130.70
Market Cap
Previous Close
115.10
Open
115.50
Last Trade
289
@
114.5
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
75,545
Shares Outstanding
83,814,526
Dividend Yield
1.05%
PE Ratio
14.89
Earnings Per Share (EPS)
7.69
Revenue
3.37B
Net Profit
644.4M

About Ipsen SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
1970
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 115.10 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 130.70 €.

Ipsen currently has 83,814,526 shares outstanding. The market capitalization of Ipsen is 9.60 € billion. Ipsen has a price to earnings ratio (PE ratio) of 14.89.

IPN Latest News

Ipsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du Nord

Ipsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du Nord PARIS, FRANCE, 2 Mai 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique...

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024.      Q1 2024  Q1...

Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024

Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024 PARIS, FRANCE, 24 avril 2024 - Ipsen (Euronext : IPN ;...

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume...

Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares

Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares Ipsen conclut un accord...

Ipsen publishes its 2023 Universal Registration Document

Ipsen publishes its 2023 Universal Registration Document    Ipsen publishes its 2023 Universal Registration Document PARIS, FRANCE, 17 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a...

Ipsen publie son Document d’enregistrement universel 2023

Ipsen publie son Document d’enregistrement universel 2023    Ipsen publie sonDocument d’enregistrement universel 2023 PARIS, FRANCE, 17 avril 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY...

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet...

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares...

Ipsen et Sutro Biopharma annoncent la signature d'un accord exclusif de licence mondiale pour un conjugué anticorps-petite molecule ciblant les tumeurs solides

Ipsen et Sutro Biopharma annoncent la signature d'un accord exclusif de licence mondiale pour un conjugué anticorps-petite molecule ciblant les tumeurs solides Ipsen obtient les droits...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.91.68738898757112.6116.4111.366340113.61495225DE
47.57.00934579439107116.4105.366004110.52228158DE
128.37.81544256121106.2116.499.775545106.77090612DE
263.32.96762589928111.2116.499.775929106.01691553DE
524.43.99636693915110.1130.799.771890110.68630299DE
1563442.236024844780.5130.7778687799.37771417DE
2609.79.25572519084104.8130.734.210975688.6605037DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
newmedman newmedman 4 minutes ago
you're a fool, but I learned that long ago. You're the guy who said that any legal outcome would be justifiable and you would accept it, you didn't, you still go to bat for this jerkoff every day.. It's rather embarrassing.
Mr. C Mr. C 5 minutes ago
So DJT is at fault because Delfin didn’t get their stuff in time?

Or should expect someone appointed by him who takes orders for a living to go against the status quo set by this admin?

Yes, if Trump was in we probably wouldn’t have this issue, but then again it might
DJT
knrorrel knrorrel 5 minutes ago
yep
JAGX
Topgun21 Topgun21 5 minutes ago
KABOOM $BLEG
BLEG
knrorrel knrorrel 5 minutes ago
sounds great
JAGX
knrorrel knrorrel 6 minutes ago
sounds great
FLES
varmit varmit 7 minutes ago
Filings coming :))))$$$$$$$$.015?????
RNVA
AAPL31415926 AAPL31415926 8 minutes ago
St Louis rocks!
NWBO
Xl175 Xl175 8 minutes ago
Should you be on a college campus somewhere? November thing will change
TGLO
Mr. C Mr. C 8 minutes ago
Curious what your rating is?
TGLO
Stock_Barber Stock_Barber 8 minutes ago
Will you EVER answer the question? Nope!

Why? We know...
SO YOU KNOW THEY ARE LYING ABOUT A NAKED SHORT POSITION HERE... YET YOU SAY NOTHING!

🤣
DBMM
Real McCoy Real McCoy 9 minutes ago
Yep and when they reject any notion that 6 year of Bioamber is “alive” it should be informative.

As you know, it is inevitable. No hope of anything else.
sluggercjb sluggercjb 9 minutes ago
I would love to wake up one morning and b $ 350 K to the good …. I’d be more than happy. Especially after the one for eight reverse split. ..$$$$$$$
RDGL
Stock_Barber Stock_Barber 10 minutes ago
You are not JUST a "supportive shareholder"...

"Supportive shareholders" don't repeatedly leak inside info!

We know...


https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Fwww.azquotes.com%2Fpicture-quotes%2Fquote-the-lady-doth-protest-too
DBMM
floridajim1 floridajim1 11 minutes ago
No one here who is positive on the prospects for VNUE is scamming anybody for personal gain. Yet, there are a small coterie of neurotics who have nothing better to do with their lives but denigrate real investors who eschew the gratuitous advice from bashers who have no financial interest in the pro
VNUE
burner67 burner67 14 minutes ago
Yeah…I don’t think so
BEGI
NewJerichoMan NewJerichoMan 15 minutes ago
Tom Brady being a savage.

https://twitter.com/_MLFootball/status/1787322928867983690
ASKH
stockyupydowny stockyupydowny 15 minutes ago
Fake Wall....
BLEG
Gusher405 Gusher405 16 minutes ago
Whatever. Again your lack of reading comprehension boggles me.

Good night.
DBMM
kgw kgw 16 minutes ago
Interesting Judy, I was going to look into doing the same as I’m getting ready to retire so I’m going to wait and see. Thanks for the info.
CBBT
kund kund 16 minutes ago
The EMA had already reviewed and you believe it because Misleading is truth teller.

How is your FUDster list? Hope clown got some work to do during his vacation.
AVXL
The Night Stalker The Night Stalker 16 minutes ago
its trying
TKMO
tnc26 tnc26 17 minutes ago
Hopefully we gunning the gas this week and start moving up nicely..
DFCO
Acme Investments Acme Investments 19 minutes ago
That post is a respectable one!! Eric will get it done he likes to have his back against the wall!! Caution should always be considered buying a .0001 stock and I think all those involved are aware of that!!
WNBD

Your Recent History

Delayed Upgrade Clock